Similarly, in human non-small-cell lung cancer (NSCLC) cells, the activation of JNK phosphorylates p53 at serine 15 and increases its stability by reducing the interaction between p53 and MDM2, thereby inducing G2/M arrest and cancer cell apoptosis [201]. The gene discussed is TP53; the disease is cancer.